A Call to scrap Anthracyclines in Breast Cancer

[tousled1]

SAN ANTONIO, Dec. 13 -- The anthracycline drugs -- long a mainstay of breast cancer chemotherapy -- only benefit a minority of women and should be mostly scrapped, a researcher said here.

Read full article:

http://www.medpagetoday.com/HematologyOncology/BreastCancer/tb/7682